A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The following article includes several classes of medications that treat type 2 diabetes. Each class works in a different way ...

GLP-1 drugs are being explored as potential treatments for a range of conditions. View on euronews ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

The current classification system presents challenges to the diagnosis and treatment of patients with diabetes mellitus ... without the risk of drug-related hypoglycemia or weight gain or imposing ...

Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.A new study ...

The lawsuit claims the companies and pharmacy benefit managers are "engaging in an ongoing conspiracy to rig the market" and inflate prices for diabetes medication ... as a class action, or ...